Her cancer was not simply something happening to her body.
It changed the rhythm of the entire household.
Cancer patients often describe treatment in clinical language—infusions, cycles, scans, surgery—but those words can obscure the ordinary life that continues around them.
Children still need breakfast.
Babies still wake at night.
Laundry accumulates.
Birthdays arrive.
Family photographs are taken.
Parents worry.
And medical appointments become entries on the calendar alongside everything else.
Rapplean's own writing repeatedly returned to those ordinary moments.
She wrote about wanting to watch her boys grow up, celebrate milestones, read bedtime stories and be present for spontaneous hugs.
Those wishes were modest in one sense.
But after a Stage IV diagnosis, they carried enormous weight.
Why Stage IV Matters
Stage IV breast cancer means cancer has spread beyond the breast and nearby lymph nodes to distant parts of the body. It is also called metastatic breast cancer.
That classification makes Rapplean's later progress especially significant—but it also means terms such as “cancer-free” require medical context.
The American Cancer Society says Stage IV breast cancer is generally considered very difficult to cure, although modern treatments can shrink tumors, control disease and allow some patients to live for years.
For many people with metastatic disease, systemic therapy continues long term, sometimes changing if the cancer begins growing again or if side effects become unacceptable.
The NCI similarly describes metastatic breast cancer treatment as focused on slowing the disease, controlling symptoms and prolonging life. Treatment choices can include chemotherapy, targeted therapy and other approaches depending on the tumor's biological characteristics.
That is why phrases such as “no evidence of disease,” “complete response” or “no active disease” can be more precise in some Stage IV situations than simply saying someone has been permanently cured.
A person can have scans showing no detectable active cancer while doctors continue treatment or surveillance because of the possibility of microscopic disease or future recurrence.
This distinction does not make such a result less meaningful.
For someone who once faced active metastatic disease, reaching a point where cancer is no longer detectable can represent an extraordinary treatment response.
The Long Road Beyond Surgery
Rapplean's treatment did not end with her mastectomy.
In September 2024, she wrote that she was continuing infusions approximately every three weeks and that her doctors had told her the Stage IV cancer was considered incurable.
At the same time, she described herself as being “in a good place” and remained determined to pursue every reasonable possibility for extending her life.
She also pursued integrative treatments outside her conventional oncology care.
Those choices were part of Rapplean's personal treatment journey, but claims made by individual integrative clinics should not be treated as equivalent to evidence from large clinical trials or standard oncology guidelines. Her documented conventional treatment—including chemotherapy, HER2-targeted drugs and surgery—aligns with established treatment approaches used for HER2-positive breast cancer.
The medical advances behind those treatments are important to understanding why a diagnosis such as hers no longer has exactly the same outlook it once did.
HER2-positive breast cancer was historically associated with aggressive behavior.
But HER2-targeted medicines transformed treatment.
Trastuzumab, pertuzumab and newer antibody-drug conjugates give oncologists multiple ways to attack tumors that carry the HER2 protein. The American Cancer Society notes that HER2-directed medicines now play central roles in treating both early and advanced HER2-positive breast cancer.
For a patient diagnosed at 32, those developments can translate into something immensely valuable:
time.
“Fighting for More Birthdays”
By July 2026, more than two years had passed since Travis' birth.
He was no longer the newborn who had spent 17 days in the NICU.
Kiersten was no longer the woman sitting at 29 weeks pregnant trying to absorb a cancer diagnosis.
On July 29, 2026, KSDK published a report describing Rapplean as “now cancer-free” while covering the expansion of the SSM Health St. Joseph Hospital Cancer Center in Lake Saint Louis, Missouri.
The timing carried its own symbolism.
SSM Health had recently completed a multimillion-dollar transformation of the Lake Saint Louis cancer center, adding clinical staff, examination rooms, infusion bays, expanded pharmacy and laboratory space, and additional oncology capacity.
SSM Health said the goal was to allow more patients in western St. Charles County and neighboring communities to receive advanced cancer care closer to home.
For Rapplean, the expansion was not an abstract health-care announcement.
Cancer centers had become part of the geography of her life.
Infusion rooms were places where hours accumulated.
Medical staff became familiar faces.
A hospital was not simply somewhere people visited when something went wrong. It was a place connected to the possibility of watching her children grow older.
The phrase associated with KSDK's coverage captured that perspective: “Fighting for more birthdays.”
Few phrases summarize her story better.
What “Cancer-Free” Means in Her Story
KSDK's July 2026 report used the term “cancer-free,” and that is understandably the phrase most likely to spread across social media.
But Rapplean's original Stage IV diagnosis makes careful wording important.
Public reporting available as of September 2026 does not provide her complete oncology records, scan reports or her treating physician's precise terminology.
So it would go beyond the available evidence to declare that her metastatic breast cancer has been permanently cured.
What can be said is powerful enough:
A woman who publicly described herself in 2024 as living with Stage IV HER2-positive inflammatory breast cancer was reported in July 2026 as cancer-free following an intensive course of treatment.
In the context of metastatic breast cancer, continued follow-up remains important even after a very strong response. The ACS notes that Stage IV disease often requires long-term systemic treatment, while NCI-supported research continues to study whether some HER2-positive metastatic patients who achieve durable complete remission may eventually be able to discontinue maintenance therapy safely.
That uncertainty is part of living after advanced cancer.
Hope and vigilance can coexist.
The Other Patient in the Story
It would be easy to tell Rapplean's story entirely through the lens of cancer.
But there was another story developing at exactly the same time.
Travis.
While his mother underwent her first rounds of chemotherapy, he was still inside her.
When doctors induced labor at 36 weeks and one day, the medical strategy shifted from protecting a fetus during maternal treatment to caring separately for mother and newborn.
He spent 17 days in the NICU, according to Rapplean.
Then he went home.
She later described him as a strong, thriving and happy baby.
His health is more than an emotional footnote.
It illustrates the complicated but increasingly evidence-based decisions that specialists can make when breast cancer is diagnosed during pregnancy.
Cancer treatment during pregnancy does not mean doctors simply ignore fetal safety.
Instead, timing becomes critical.